Contains two oral antidiabetic drugs used in the management of type 2 diabetes: rosiglitazone maleate, a thiazolidinedione, and glimepiride, a sulfonylurea. Recommended starting dose: 4mg rosiglitazone/1mg glimepiride once daily with the first meal of the day. Maximum recommended daily dose: 8mg rosiglitazone/4mg glimepiride. Active Ingredients: Rosiglitazone maleate, glimepiride.
Product Category:
Non-Insulin MedicationsSub-category:
Combination ProductsProduct Features:
- Contact manufacturer for further details
Other Features:
How Supplied/Sizing:
Tablet: 4mg/1mg, 4mg/2mg, 4mg/4mg, 8mg/2mg, 8mg/4mg (rosiglitazone/glimepiride).
Company information:
GlaxoSmithKline [1]
- Street:
- One Franklin Plaza, P.O. Box 7929
- City:
- Philadelphia ,
- Province:
- Pennsylvania
- Postal Code:
- 19101
- Country:
- United States
GlaxoSmithKline is one of the industry leaders with an estimated 7% of the world's pharmaceutical market. Discovers, develops and delivers new medicines, vaccines and other healthcare products to help people do more, feel better and live longer.
Website:
www.gsk.com
Toll free:
1-888-825-5249